PLRX · Company research

Pliant Therapeutics, Inc. (PLRX): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

14records availableHealthcare

Stock News & Events data

Database-backed records only

14 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Pliant Therapeutics (PLRX) Edges Higher: Shares Hold the $1.00 Line - Sentiment Extreme - https://www.siam.in/Pliant Therapeutics (PLRX) Edges Higher: Shares Hold the $1.00 Line - Sentiment Extreme https://www.siam.in/View source ↗https://www.siam.in/Oct 9, 2026neutral00.6
David Raben receives a 575,000-share option at $1.05 per share from Pliant Therapeutics (PLRX). - Stock TitanDavid Raben receives a 575,000-share option at $1.05 per share from Pliant Therapeutics (PLRX). Stock TitanView source ↗Stock TitanOct 2, 2026neutral00.6
[Form 3] PLIANT THERAPEUTICS, INC. Initial Statement of Beneficial Ownership - Stock Titan[Form 3] PLIANT THERAPEUTICS, INC. Initial Statement of Beneficial Ownership Stock TitanView source ↗Stock TitanOct 2, 2026neutral00.6
Pliant Therapeutics (PLRX) Slips 1.77% to $1.11, Testing Support Near $1.05 - Change of Character - www.dars.gov.etPliant Therapeutics (PLRX) Slips 1.77% to $1.11, Testing Support Near $1.05 - Change of Character www.dars.gov.etView source ↗www.dars.gov.etSep 20, 2026neutral00.6
Pliant Therapeutics (PLRX) Slips 1.77% to $1.11, Testing Support Near $1.05 - Continuation Pattern Picks - dars.gov.etPliant Therapeutics (PLRX) Slips 1.77% to $1.11, Testing Support Near $1.05 - Continuation Pattern Picks dars.gov.etView source ↗dars.gov.etSep 20, 2026neutral00.6
Pliant Therapeutics (PLRX) Slips 1.77% to $1.11, Testing Support Near $1.05 - BPI Bear Correction - https://www.siam.in/Pliant Therapeutics (PLRX) Slips 1.77% to $1.11, Testing Support Near $1.05 - BPI Bear Correction https://www.siam.in/View source ↗https://www.siam.in/Sep 20, 2026neutral00.6
Here's Why We're Watching Pliant Therapeutics' (NASDAQ:PLRX) Cash Burn Situation - Simply Wall StreetHere's Why We're Watching Pliant Therapeutics' (NASDAQ:PLRX) Cash Burn Situation Simply Wall StreetView source ↗Simply Wall StreetAug 19, 2026neutral00.6
Pliant Therapeutics (PLRX) Edges Higher Amid Tight Trading Range — Key Levels in Focus - Dividend Growth Stocks - www.dars.gov.etPliant Therapeutics (PLRX) Edges Higher Amid Tight Trading Range — Key Levels in Focus - Dividend Growth Stocks www.dars.gov.etView source ↗www.dars.gov.etJul 28, 2026neutral00.6
PLRX Forecast — Price Target — Prediction for 2027 - TradingViewPLRX Forecast — Price Target — Prediction for 2027 TradingViewView source ↗TradingViewJun 25, 2026neutral00.6
Pliant Therapeutics: A Reverse Arbitrage Opportunity Driven By A Poison Pill Expiration - Seeking AlphaPliant Therapeutics: A Reverse Arbitrage Opportunity Driven By A Poison Pill Expiration Seeking AlphaView source ↗Seeking AlphaFeb 24, 2026neutral00.6
Pliant Therapeutics (PLRX) Stock Forecast and Price Target 2026 $PLRX - MarketBeatPliant Therapeutics (PLRX) Stock Forecast and Price Target 2026 $PLRX MarketBeatView source ↗MarketBeatMay 11, 2024neutral00.6
symbol__ Stock Quote Price and Forecast - CNNsymbol__ Stock Quote Price and Forecast CNNView source ↗CNNMar 25, 2024neutral00.6
Pliant Therapeutics, Inc. (PLRX) Stock Price, News, Quote & History - Yahoo! Finance CanadaPliant Therapeutics, Inc. (PLRX) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaJun 5, 2020neutral00.6
Pliant Therapeutics, Inc. Common Stock (PLRX) Historical Quotes - NasdaqPliant Therapeutics, Inc. Common Stock (PLRX) Historical Quotes NasdaqView source ↗NasdaqMay 28, 2020neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.